Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Kenvue

RFK Jr.'s planned report linking Tylenol to autism crashes shares of parent company Kenvue

RFK Jr. is preparing a report that will allegedly claim a link between prenatal Tylenol (acetaminophen) use and autism.

Fortune

Health Secretary RFK Jr to link Autism and Tylenol use in pregnancy sending company’s stock price spiraling

A report from the Department of Health and Human Services, touted by Trump and Kennedy in April, is expected to be published this month

The Independent UK

Tylenol In The Firing Line: RFK Jr. Autism Study Triggers Outrage, Market Rout And Big Pharma Panic

RFK Jr.'s autism study linking Tylenol in pregnancy to disorders sparks Big Pharma panic, political backlash and a fierce debate over corporate power.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

RFK Jr. To Link Tylenol Use To Autism: Report

Health Secretary Robert F. Kennedy Jr. is preparing to release a report suggesting that the use of a common over-the-counter pain reliever during pregnancy may be tied to a higher risk of autism.

Benzinga

Kenvue Stock Outlook: Is Wall Street Bullish or Bearish?

Kenvue has outpaced the broader market over the past year, and analysts remain cautiously optimistic about the stock’s prospects.

Barchart

Kenvue Stock Has Unusual Put Option Activity After Lower Q2 Sales and CEO Firing

Kenvue, which manufactures Band-Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO had left. Put options are showing unusually high volume today.

Barchart

Asian shares mostly decline as worries continue over Trump's tariffs

Asian shares are trading mostly lower as worries about President Donald Trump’s latest updates to his tariffs weighed on investor sentiments

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Tylenol-Maker Kenvue Launches Turnaround Plans. How Should You Play KVUE Stock Here?

Kenvue Inc ousted its chief executive and announced a strategic review on Monday. Jefferies says KVUE shares could rally to $27.

Barchart

Tylenol parent Kenvue has a new CEO, and he has lots of work to do to mollify activist investors

The company will likely focus on off-loading smaller beauty brands.

Fortune

Is Kenvue Stock Outperforming the Nasdaq?

Despite its recent underperformance, Kenvue has outpaced the Nasdaq over the past year, and analysts remain moderately bullish on the stock’s prospects.

Barchart

Kenvue Fights to Shield Brands Like Listerine and Tylenol Amid £112m Tariff Shock

Kenvue customers are expected to be prepared for price hikes as companies that sell directly to consumers grapple with rising costs.

International Business Times UK

Are Wall Street Analysts Predicting Kenvue Stock Will Climb or Sink?

Kenvue has outpaced the broader market over the past year, and Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

2 Under-the-Radar Consumer Staples Stocks With Big Dividends

Edgewell and Kenvue are under-the-radar consumer staples stocks poised to gain as the U.S. dollar declines. Learn why they may boost your income portfolio.

MarketBeat

Is Wall Street Bullish or Bearish on Kenvue Stock?

Despite Kenvue trailing the broader market over the past year, Wall Street analysts maintain a moderately bullish outlook on the stock's potential.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

How Is Kenvue’s Stock Performance Compared to Other Consumer Defensive Stocks

With Kenvue slightly lagging behind other consumer defensive stocks over the past year, Wall Street remains cautiously optimistic about its prospects.

International Business Times

Johnson & Johnson Risks UK Lawsuit Over Talc Cancer Claim

UK claimants announced Wednesday legal action against US pharmaceutical and cosmetics giant Johnson & Johnson, alleging that women diagnosed with cancers were exposed to asbestos in the company's talcum powder.

Barchart

What’s Behind the Rally in Kenvue Stock Today?

Starboard Value is reportedly eyeing changes at KVUE as the stock underperforms the broader market.

Barchart

Kenvue Stock: Is KVUE Outperforming the Consumer Defensive Sector?

Kenvue has recently outperformed the consumer defensive sector, and Wall Street analysts are moderately bullish about the stock’s prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

3 Defensive Dividend Stocks to Protect Against Pre-Election Volatility

As the U.S. presidential election nears, here are three defensive dividend-paying stocks to help shield your portfolio from pre-election volatility.

Barchart

This Dividend Aristocrat Just Had Its Best Day Ever After Earnings

This dividend aristocrat crushed Q2 earnings and issued strong guidance, and still has some fuel left in the tank for more growth.

Barchart

3 Dividend Stocks Set to Triple Your Income in the Next Decade

Looking for a lifetime of increasing dividends? Here's 3 stocks that could fit the bill.

The Independent UK

This Morning’s Dr Zoe Williams: Nobody should be smoking at home where there’s a child or pregnant mother

Quitting smoking can be extremely difficult, but there are lots of treatments options out there to help.

Barchart

What to Expect From Kenvue's Q2 2024 Earnings Report

Kenvue is all set to announce its second-quarter results this month, and analysts forecast a single-digit decline in the company’s bottom-line figure.

Barchart

Is Kenvue Stock Underperforming the Dow?

While Kenvue's shares have notably lagged behind the Dow Jones in the past year, analysts hold a moderately bullish outlook on the stock.

Barchart

3 High-Yield Dividend Stocks to Build a Passive Income Stream

When the market pulls back, it's an opportunity to invest in high-yield dividend stocks like Kenvue, Enterprise Products Partners, and Verizon, which offer attractive yields and growth potential.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Department of Health and Human Services

Verizon Communications Inc

114 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.